[A case of complete regression of liver metastases by treatment with Futraful supposition].

Abstract

The patient was a 57-year-old man abnormalities indicated in examinations by X-ray and ultrasonography in February, 1991. X-ray and endoscopic examination revealed a Borrmann type 3 carcinoma in the posterior wall and lesser curvature of the upper body of the stomach. The liver was swollen to 3 fingerbreadths on the right mid-clavicular line. Multiple liver metastases were revealed by computed tomography (CT). Proximal gastrectomy was done. From March 24, 1991, a Futraful suppository (1,500 mg/day) was given daily. After 4 months, CT showed the reduction and partial disappearance of the low-density areas of the liver. After 2 years and 7 months, CT showed very small low-density areas, which completely disappeared by April, 1998. The patient has had a good quality of life. According to the General Rules for Gastric Cancer Study, the patient belongs to the class of complete response.

• Authors: M Noji, T Bandoh, T Isoyama, S Nagaoka, M Fujiwara, T Takemura
• Journal: Gan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 27 Issue 2 Pg. 285-8 (Feb 2000) ISSN: 0385-0684 [Print] Japan
• PMID: 10700902 (Publication Type: Case Reports, English Abstract, Journal Article)

Chemical References

• Antimetabolites, Antineoplastic
• Suppositories
• Tegafur

Topics

• Adenocarcinoma (drug therapy, secondary)
• Antimetabolites, Antineoplastic (administration & dosage)
• Humans
• Liver Neoplasms (secondary)
• Male
• Middle Aged
• Remission Induction
• Stomach Neoplasms (drug therapy, pathology)
• Suppositories
• Tegafur (administration & dosage)